Bausch Health Companies Inc. (BHC)
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.
Address
2150 ST. ELZEAR BLVD. WEST
QUEBEC, A8 H7L 4A8
Founded
1994
Number of Employees
20,270
Website
http://www.bauschhealth.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s ) |
$1,354 | $72,344 | - | $942 | - | - | - | - | - | - | - | $24,880 |
Average Price | $134.12 | $170.45 | - | $16.95 | - | - | - | - | - | - | - | $152.30 |
# Shares Purchased | 10,099 | 424,437 | - | 55,571 | - | - | - | - | - | - | - | 163,369 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | -95.5% | -96.5% | - | -64.6% | - | - | - | - | - | - | - | -96.1% |
S&P 500 Return to Date | 181.9% | 173.0% | - | 129.7% | - | - | - | - | - | - | - | 161.5% |
Excess Total Return | -277.4% | -269.4% | - | -194.3% | - | - | - | - | - | - | - | -257.6% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | 1% | 1% | - | 9% | - | - | - | - | - | - | - | 1% |
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)